Research and Development of Cilostazol : An Antiplatelet Agent

Yakugaku Zasshi - Japan
doi 10.1248/yakushi1947.120.12_1247
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Pharmaceutical Society of Japan

Related search

Antiplatelet Treatment With Cilostazol After Stent Implantation

Heart
Cardiovascular MedicineCardiology
1998English

An Agent That Can Prohibit Microbial Development and Infection

2005English

Addition of Cilostazol to Conventional Dual Antiplatelet Therapy Reducing the Risk of Cardiac Events and Restenosis After Drug-Eluting Stent Implantation: A Meta-Analysis

Heart
Cardiovascular MedicineCardiology
2012English

Antiplatelet Agent Plus Small Dose of Anticoagulant for Atherosclerotic Vascular Diseases―COMPASS Trial

Japanese Journal of Thrombosis and Hemostasis
2019English

Research and Development as an Investment

1989English

The Effect of Cilostazol on the Angiographic Outcome of Drug-Eluting Coronary Stents Angiographic Analysis of the CILON-T (Influence of CILostazol-Based Triple Antiplatelet Therapy ON Ischemi Complication After Drug-Eluting StenT Implantation) Trial

International Heart Journal
MedicineCardiovascular MedicineCardiology
2017English

An Oral Formulation of Cilostazol Nanoparticles Enhances Intestinal Drug Absorption in Rats

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2017English

The Miracle of Peer Review and Development in Science: An Agent-Based Model

Scientometrics
Computer Science ApplicationsSocial SciencesLibraryInformation Sciences
2017English

The Vascular Effects of Cilostazol

Canadian Journal of Cardiology
Cardiovascular MedicineCardiology
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy